Withdrawn before it began
Randomized AmnioFix Study During Radical Prostatectomy
NCT02645591 · M.D. Anderson Cancer Center · Updated 22 Nov 2016
- What is being tested
- Robotic Assisted Laparoscopic Radical Prostatectomy (RARP); AmnioFix®; Questionnaire
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 35 years to 75 years. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started Nov 2016. Registered 1 Jan 2016.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical research study is to learn about the safety and the effectiveness of using AmnioFix® (dehydrated human amnion/chorion membrane, also called dHACM) to help improve the return of erectile function and bladder control in patients after robotic assisted laparoscopic radical prostatectomy (RARP). dHACM is a section of tissue made from part of the placenta donated by a mother during a C-section. It looks like a small piece of tissue paper and is wrapped around the nerve bundles in the surgical area. The tissue may help the body's normal healing process.